Published in PLoS One on May 31, 2013
Latest consensus and update on protein-energy wasting in chronic kidney disease. Curr Opin Clin Nutr Metab Care (2015) 1.00
Changes in Body Composition in the Two Years after Initiation of Haemodialysis: A Retrospective Cohort Study. Nutrients (2016) 0.75
Bone is Not Alone: the Effects of Skeletal Muscle Dysfunction in Chronic Kidney Disease. Curr Osteoporos Rep (2015) 0.75
Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci (2000) 15.54
Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes (1997) 4.15
Lower extremity performance in nondisabled older persons as a predictor of subsequent hospitalization. J Gerontol A Biol Sci Med Sci (2000) 2.81
Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol (2010) 2.68
Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr (2006) 2.67
Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: A randomized, controlled trial. J Am Soc Nephrol (2006) 2.38
Progressive exercise for anabolism in kidney disease (PEAK): a randomized, controlled trial of resistance training during hemodialysis. J Am Soc Nephrol (2007) 2.06
Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients. Kidney Int (2006) 1.97
Resistance training to counteract the catabolism of a low-protein diet in patients with chronic renal insufficiency. A randomized, controlled trial. Ann Intern Med (2001) 1.86
Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy. J Am Soc Nephrol (2006) 1.82
Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. Kidney Int (2005) 1.80
Review of muscle wasting associated with chronic kidney disease. Am J Clin Nutr (2010) 1.55
Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients. Kidney Int (2010) 1.55
Muscle atrophy in patients receiving hemodialysis: effects on muscle strength, muscle quality, and physical function. Kidney Int (2003) 1.54
The effects of exercise training on muscle atrophy in haemodialysis patients. Nephrol Dial Transplant (1998) 1.33
Determinants of physical performance in ambulatory patients on hemodialysis. Kidney Int (2001) 1.30
Patients receiving maintenance dialysis have more severe functionally significant skeletal muscle wasting than patients with dialysis-independent chronic kidney disease. Nephrol Dial Transplant (2006) 1.23
Endurance exercise training during haemodialysis improves strength, power, fatigability and physical performance in maintenance haemodialysis patients. Nephrol Dial Transplant (2005) 1.19
Association of age with muscle mass, fat mass and fat distribution in non-diabetic haemodialysis patients. Nephrol Dial Transplant (2005) 1.08
Nutrition and chronic kidney disease. Kidney Int (2011) 1.06
Characteristics and effects of inflammation in end-stage renal disease. Semin Dial (2003) 1.03
Standardized thigh muscle area measured by computed axial tomography as an alternate muscle mass index for nutritional assessment of hemodialysis patients. Am J Clin Nutr (2000) 1.03
Increased muscle protein breakdown in chronic hemodialysis patients with type 2 diabetes mellitus. Kidney Int (2005) 1.03
Dialysis-related carnitine disorder. Semin Dial (2006) 1.02
Exercise performance falls over time in patients with chronic kidney disease despite maintenance of hemoglobin concentration. Clin J Am Soc Nephrol (2006) 1.01
Effects of exercise training on aerobic and functional capacity of end-stage renal disease patients. Clin Physiol Funct Imaging (2002) 0.99
Creatinine index and lean body mass are excellent predictors of long-term survival in haemodiafiltration patients. Nephrol Dial Transplant (2004) 0.98
Abnormal mitochondrial function and muscle wasting, but normal contractile efficiency, in haemodialysed patients studied non-invasively in vivo. Nephrol Dial Transplant (2004) 0.98
Molecular mechanisms activating muscle protein degradation in chronic kidney disease and other catabolic conditions. Eur J Clin Invest (2005) 0.93
Proteolysis by the ubiquitin-proteasome system and kidney disease. J Am Soc Nephrol (2011) 0.93
Insulin resistance and muscle wasting in non-diabetic end-stage renal disease patients. Nephrol Dial Transplant (2007) 0.91
Subjective and objective physical limitations in high-functioning renal dialysis patients. Nephrol Dial Transplant (2004) 0.88
Protein turnover and amino acid transport kinetics in end-stage renal disease. Am J Physiol Endocrinol Metab (2003) 0.86
Effect of diabetes mellitus on muscle size and strength in patients receiving dialysis therapy. Am J Kidney Dis (2006) 0.86
Adipose tissue and inflammation in chronic kidney disease. Contrib Nephrol (2006) 0.85
The haemodynamic and metabolic effects of hypertonic-glucose and amino-acid-based peritoneal dialysis fluids. Nephrol Dial Transplant (2006) 0.84
The uremic environment and muscle dysfunction in man and rat. Nephron Physiol (2005) 0.83
Uremic myopathy. Kidney Int (2002) 0.83
Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol (2009) 3.19
Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol (2010) 2.69
Use of electronic results reporting to diagnose and monitor AKI in hospitalized patients. Clin J Am Soc Nephrol (2012) 2.44
A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis (2008) 2.38
Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning). Clin J Am Soc Nephrol (2011) 2.08
Plasma pyrophosphate and vascular calcification in chronic kidney disease. Nephrol Dial Transplant (2009) 2.02
Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol (2007) 1.92
A systematic review of the clinical effects of reducing dialysate fluid temperature. Nephrol Dial Transplant (2006) 1.80
Dialysis-induced regional left ventricular dysfunction is ameliorated by cooling the dialysate. Clin J Am Soc Nephrol (2006) 1.78
Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol (2009) 1.78
Peritoneal dialysis is not associated with myocardial stunning. Perit Dial Int (2010) 1.52
Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis. Am J Kidney Dis (2006) 1.49
Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant (2005) 1.48
Hypertonic glucose-based peritoneal dialysate is associated with higher blood pressure and adverse haemodynamics as compared with icodextrin. Nephrol Dial Transplant (2005) 1.43
Prevalence and associations of limited health literacy in chronic kidney disease: a systematic review. Nephrol Dial Transplant (2012) 1.24
The acute cardiac effects of dialysis. Semin Dial (2007) 1.17
Markers of arterial stiffness are risk factors for progression to end-stage renal disease among patients with chronic kidney disease stages 4 and 5. Nephron Clin Pract (2007) 1.17
Matrix metalloproteinase-2 and -9 exacerbate arterial stiffening and angiogenesis in diabetes and chronic kidney disease. Cardiovasc Res (2009) 1.15
Recurrent circulatory stress: the dark side of dialysis. Semin Dial (2010) 1.12
Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease. Circulation (2009) 1.12
Calcium exposure and removal in chronic hemodialysis patients. J Ren Nutr (2006) 1.12
Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness. Nephrol Dial Transplant (2005) 1.11
Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3. Clin J Am Soc Nephrol (2011) 1.09
Haemodialysis is associated with a pronounced fall in myocardial perfusion. Nephrol Dial Transplant (2008) 1.09
Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors. BMC Infect Dis (2012) 1.08
Pediatric myocardial stunning underscores the cardiac toxicity of conventional hemodialysis treatments. Clin J Am Soc Nephrol (2009) 1.08
Dialysis-induced myocardial stunning: the other side of the cardiorenal syndrome. Rev Cardiovasc Med (2011) 1.07
Angiopoietin-2 levels predict mortality in CKD patients. Nephrol Dial Transplant (2011) 1.05
Automated peritoneal dialysis has significant effects on systemic hemodynamics. Perit Dial Int (2006) 1.02
Are there neurological consequences of recurrent intradialytic hypotension? Semin Dial (2012) 1.02
Risk profile in chronic kidney disease stage 3: older versus younger patients. Nephron Clin Pract (2011) 1.02
Anthropomorphic measurements that include central fat distribution are more closely related with key risk factors than BMI in CKD stage 3. PLoS One (2012) 1.01
Online conductivity monitoring: validation and usefulness in a clinical trial of reduced dialysate conductivity. ASAIO J (2005) 1.01
Effects of arteriovenous fistula formation on arterial stiffness and cardiovascular performance and function. Nephrol Dial Transplant (2011) 1.00
Development of a formula for estimation of sodium intake from spot urine in people with chronic kidney disease. Nephron Clin Pract (2014) 1.00
Hemodialysis-induced left ventricular dysfunction is associated with an increase in ventricular arrhythmias. Ren Fail (2008) 1.00
Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care. BMC Fam Pract (2013) 1.00
Defining the cause of death in hospitalised patients with acute kidney injury. PLoS One (2012) 0.99
Venography at insertion of tunnelled internal jugular vein dialysis catheters reveals significant occult stenosis. Nephrol Dial Transplant (2004) 0.99
How to measure proteinuria? Curr Opin Nephrol Hypertens (2008) 0.99
Individualised dialysate temperature improves intradialytic haemodynamics and abrogates haemodialysis-induced myocardial stunning, without compromising tolerability. Blood Purif (2011) 0.97
Assessment of haemodialysis adequacy by ionic dialysance: intra-patient variability of delivered treatment. Nephrol Dial Transplant (2003) 0.95
Tissue-advanced glycation end product concentration in dialysis patients. Clin J Am Soc Nephrol (2009) 0.95
Benefits of regular walking exercise in advanced pre-dialysis chronic kidney disease. Nephrol Dial Transplant (2011) 0.95
Hemodialysis-associated cardiomyopathy: a newly defined disease entity. Semin Dial (2014) 0.94
Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS). Kidney Int (2003) 0.94
Vascular calcification is associated with impaired microcirculatory function in chronic haemodialysis patients. Nephron Clin Pract (2008) 0.93
A non-invasive, on-line deuterium dilution technique for the measurement of total body water in haemodialysis patients. Nephrol Dial Transplant (2008) 0.92
Analysis of factors associated with variability in haemodialysis adequacy. Nephrol Dial Transplant (2004) 0.90
Renal Association Clinical Practice Guideline on detection, monitoring and management of patients with CKD. Nephron Clin Pract (2011) 0.90
Effects of acetate-free double-chamber hemodiafiltration and standard dialysis on systemic hemodynamics and troponin T levels. ASAIO J (2006) 0.88
Troponin T for the detection of dialysis-induced myocardial stunning in hemodialysis patients. Clin J Am Soc Nephrol (2012) 0.88
Hemoglobin variability with epoetin beta and continuous erythropoietin receptor activator in patients on peritoneal dialysis. Perit Dial Int (2011) 0.87
Determinants of arterial stiffness in chronic kidney disease stage 3. PLoS One (2013) 0.86
The haemodynamic and metabolic effects of hypertonic-glucose and amino-acid-based peritoneal dialysis fluids. Nephrol Dial Transplant (2006) 0.84
Use of albumin dialysis in the treatment of hepatic and renal dysfunction due to paracetamol intoxication. Nephrol Dial Transplant (2002) 0.84
The reimbursement and cost of acute kidney injury: a UK hospital perspective. Nephron Clin Pract (2014) 0.83
Comparison of progressive conductivity reduction with diacontrol and standard dialysis. ASAIO J (2007) 0.82
Determinants of survival in patients receiving dialysis in Libya. Hemodial Int (2012) 0.82
Arterial stiffness and functional properties in chronic kidney disease patients on different dialysis modalities: an exploratory study. Nephrol Dial Transplant (2010) 0.81
Preventing catheter related infections in haemodialysis patients. Curr Opin Nephrol Hypertens (2006) 0.81
Circulating endotoxaemia and frequent haemodialysis schedules. Nephron Clin Pract (2014) 0.81
Chronic kidney disease 10 years on: what have we learned? Curr Opin Nephrol Hypertens (2012) 0.81
N-terminal Pro-B-type natriuretic peptide and its correlation to haemodialysis-induced myocardial stunning. Nephron Clin Pract (2013) 0.81
Higher arteriovenous fistulae blood flows are associated with a lower level of dialysis-induced cardiac injury. Hemodial Int (2009) 0.81
The assessment of baroreflex sensitivity in patients with chronic kidney disease: implications for vasomotor instability. Curr Opin Nephrol Hypertens (2005) 0.81
The vicious cycle of dialysis-induced cardiac injury--are dynamic changes in diastolic function involved? Am J Kidney Dis (2013) 0.81
Online measurement of haemoglobin concentration. Nephrol Dial Transplant (2005) 0.80
Socio-economic disparities in the distribution of cardiovascular risk in chronic kidney disease stage 3. Nephron Clin Pract (2013) 0.80
Myocardial contractile function and intradialytic hypotension. Hemodial Int (2009) 0.80
Adherence of tunnelled haemodialysis catheter to superior vena caval stent: successful percutaneous removal. Nephrol Dial Transplant (2003) 0.80
Incident isolated 1,25(OH)(2)D(3) deficiency is more common than 25(OH)D deficiency in CKD. J Nephrol (2012) 0.80
Defining renal risk. Curr Opin Nephrol Hypertens (2007) 0.80
The impact of antihypertensive drug therapy on endotoxemia in elderly patients with chronic kidney disease. Clin J Am Soc Nephrol (2011) 0.80